Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine concentration comparison for interscalene block in arthroscopic shoulder surgery
ACTRN12611000433909Phase 4Completed
- Sponsor
- Abalone Bio
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain (4 arms), sponsored by Abalone Bio. Primary endpoint: Duration before analgesic effect of block wears off as reported by the patient. Started Jan 2012; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12611000433909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000433909.